![Gregory Gorgas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregory Gorgas
Algemeen Directeur bij
ARTELO BIOSCIENCES, INC.
Vermogen: 1 590 $ op 31-05-2026
Profiel
Gregory D.
Gorgas was the founder of Theragence, Inc., founded in 2009, where the title held was Managing Director from 2009 to 2011.
Current jobs include President, CEO, Secretary & Director at Artelo Biosciences, Inc. starting in 2025; Director at Klotho Therapeutics, Inc.; and Director at Theragence, Inc. Former jobs include Senior Director-Global & United States Marketing at Biogen, Inc. from 2006 to 2008; Senior Vice President-Commercial & Corporate at Mast Therapeutics, Inc. from 2011 to 2017; and Senior Vice President-Commercial at Savara, Inc. Education includes undergraduate studies at The California State University and an MBA from the University of Phoenix.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 20-02-2026 | 1.136 ( 0,05% ) | 1 590 $ | 31-05-2026 |
Actieve functies van Gregory Gorgas
| Bedrijven | Functie | Begin |
|---|---|---|
| ARTELO BIOSCIENCES, INC. | Algemeen Directeur | 03-04-2017 |
Klotho Therapeutics, Inc.
 Klotho Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops patent-pending Klotho protein for diseases of aging, cancer, and kidney disease | Directeur/Bestuurslid | - |
Theragence, Inc.
 Theragence, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical preparations | Directeur/Bestuurslid | - |
Eerdere bekende functies van Gregory Gorgas
| Bedrijven | Functie | Einde |
|---|---|---|
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Corporate Officer/Principal | 01-01-2017 |
| SAVARA INC. | Corporate Officer/Principal | 28-12-2016 |
Theragence, Inc.
Theragence, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical preparations | Algemeen Directeur | 01-07-2011 |
| BIOGEN INC. | Verkoop & Marketing | 01-10-2008 |
Opleiding van Gregory Gorgas
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
70
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Health Technology |
Artelo Biosciences, Inc.
 Artelo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops endocannabinoid system modulating therapeutics | Health Technology |
The California State University
 The California State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Phoenix
 University of Phoenix Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theragence, Inc.
Theragence, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical preparations | Health Technology |
Savara, Inc.
 Savara, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals to treat respiratory diseases | Health Technology |
Klotho Therapeutics, Inc.
Klotho Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops patent-pending Klotho protein for diseases of aging, cancer, and kidney disease | Commercial Services |
